INFIQ — Infinity Pharmaceuticals Share News
0.000.00%
Last trade - 00:00IndustrialsHighly SpeculativeMicro Cap
- $0.00m
- -$17.75m
- $2.59m
Brief: Infinity Pharmaceuticals Inc - On December 28, Got Notice From Nasdaq Notifying That Co Did Not Satisfy Certain Continued Listing Requirement
Infinity Pharmaceuticals touches three-month low after Q3 miss
Infinity Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary
Infinity Pharmaceuticals Inc expected to post a loss of 6 cents a share - Earnings Preview
Infinity Pharmaceuticals Inc expected to post a loss of 6 cents a share - Earnings Preview
Brief: Infinity Pharmaceuticals Says On Aug 24, Co Received Letter From Nasdaq Notifying Co That It Had Regained Compliance With Minimum Bid Requirement
Infinity Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Infinity Pharmaceuticals Inc expected to post a loss of 15 cents a share - Earnings Preview
Brief: Infinity Pharmaceuticals - On May 24, Co Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
U.S. RESEARCH ROUNDUP-Eli Lilly, Gilead Sciences, Upwork
Infinity Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Brief: Infinity Pharmaceuticals Reports First Quarter 2022 Financial Results
Infinity Pharmaceuticals Inc expected to post a loss of 13 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Astec Industries, ChampionX, Schlumberger NV
U.S. STOCKS ON THE MOVE-Baidu, Clarus, cruise operators
U.S. STOCKS ON THE MOVE-Datadog Inc, Expensify Inc, Walgreens
Infinity Pharma an attractive M&A target - Truist Securities
U.S. RESEARCH ROUNDUP- Codexis, Ionis Pharmaceuticals, Travere Therapeutics
Infinity Pharma: Second top pct gainer on Nasdaq Biotech index after earnings results